296 related articles for article (PubMed ID: 35842679)
61. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
62. Preoperative prediction of pelvic lymph nodes metastasis in early-stage cervical cancer using radiomics nomogram developed based on T2-weighted MRI and diffusion-weighted imaging.
Wang T; Gao T; Yang J; Yan X; Wang Y; Zhou X; Tian J; Huang L; Zhang M
Eur J Radiol; 2019 May; 114():128-135. PubMed ID: 31005162
[TBL] [Abstract][Full Text] [Related]
63. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
Front Oncol; 2022; 12():843991. PubMed ID: 35692757
[TBL] [Abstract][Full Text] [Related]
64. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
Wagner-Larsen KS; Hodneland E; Fasmer KE; Lura N; Woie K; Bertelsen BI; Salvesen Ø; Halle MK; Smit N; Krakstad C; Haldorsen IS
Cancer Med; 2023 Oct; 12(20):20251-20265. PubMed ID: 37840437
[TBL] [Abstract][Full Text] [Related]
65. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
Binbin T; Lingying W; Manni H; Jusheng A; Ning L
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
[TBL] [Abstract][Full Text] [Related]
66. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
67. Feasibility of MRI-based radiomics features for predicting lymph node metastases and VEGF expression in cervical cancer.
Deng X; Liu M; Sun J; Li M; Liu D; Li L; Fang J; Wang X; Zhang J
Eur J Radiol; 2021 Jan; 134():109429. PubMed ID: 33290975
[TBL] [Abstract][Full Text] [Related]
68. A MRI radiomics-based model for prediction of pelvic lymph node metastasis in cervical cancer.
Wang T; Li YY; Ma NN; Wang PA; Zhang B
World J Surg Oncol; 2024 Feb; 22(1):55. PubMed ID: 38365759
[TBL] [Abstract][Full Text] [Related]
69. Comparison of MRI and CT-Based Radiomics and Their Combination for Early Identification of Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.
Li J; Zhang HL; Yin HK; Zhang HK; Wang Y; Xu SN; Ma F; Gao JB; Li HL; Qu JR
J Magn Reson Imaging; 2023 Sep; 58(3):907-923. PubMed ID: 36527425
[TBL] [Abstract][Full Text] [Related]
70. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
[TBL] [Abstract][Full Text] [Related]
71. Performance of Pretreatment MRI-Based Radiomics in Recombinant Human Endostatin Plus Concurrent Chemoradiotherapy Response Prediction in Nasopharyngeal Carcinoma: A Retrospective Study.
Huang L; Yang Z; Kang M; Ren H; Jiang M; Tang C; Hu Y; Shen M; Lin H; Long L
Technol Cancer Res Treat; 2023; 22():15330338231160619. PubMed ID: 37094106
[TBL] [Abstract][Full Text] [Related]
72. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
73. MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
Kang HB; Kim SH; Lee JH; Lee HC; Kang NK; Lee JH
Int J Clin Oncol; 2024 May; 29(5):620-628. PubMed ID: 38530569
[TBL] [Abstract][Full Text] [Related]
74. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
Hu K; Wang W; Liu X; Meng Q; Zhang F
Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
[TBL] [Abstract][Full Text] [Related]
75. Prognostic value of
Song Y; Tian Y; Lu X; Chen G; Lv X
Med Phys; 2024 Jan; ():. PubMed ID: 38252704
[TBL] [Abstract][Full Text] [Related]
76. Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.
Zhao S; Su Y; Duan J; Qiu Q; Ge X; Wang A; Yin Y
J Bone Oncol; 2019 Dec; 19():100263. PubMed ID: 31667064
[TBL] [Abstract][Full Text] [Related]
77. MRI radiomics combined with clinicopathologic features to predict disease-free survival in patients with early-stage cervical cancer.
Jiang X; Song J; Duan S; Cheng W; Chen T; Liu X
Br J Radiol; 2022 Aug; 95(1136):20211229. PubMed ID: 35604668
[TBL] [Abstract][Full Text] [Related]
78. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
[TBL] [Abstract][Full Text] [Related]
79. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
[No Abstract] [Full Text] [Related]
80. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
Zhao B; Cao K; Li XT; Zhu HT; Sun YS
BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
